Professional Webinars | Aplastic Anemia & MDS International Foundation Return to top.

Professional Webinars

For a full list of our upcoming conferences for health care professionals see: Professionals » Professional Conferences.

CE Accreditation Period: 07/31/2023 to 08/01/2024
Topic(s): Bone Marrow Transplant, Myelodysplastic Syndromes (MDS)

MDS Risk Stratification and Curative Treatment: The Expanding Role of HCT with IPSS-M 

Now available On-Demand
Earn up to 1.0 CME/CE credits* 
Learn from transplant and hematology/oncology experts in a discussion on the current state of HCT eligibility and when to consider HCT for patients with MDS. They highlight results from recently published studies on the International Prognostic Scoring System (IPSS) evolving to the inclusion of molecular disease markers (IPSS-M), referral patterns for HCT in MDS, and the latest consensus guidelines for the use of HCT in treating MDS. They also discuss how advances in HCT facilitate improved survival and preserve quality of life. 
•Robert P. Hasserjian, MD 
Professor of Pathology - Massachusetts General Hospital/ Harvard Medical School 
•Andrew Brunner, MD
Assistant in Medicine, Division of Hematology/Oncology - Massachusetts General Hospital
Assistant Professor - Harvard Medical School 
•Bart L. Scott, MD
Professor, Transplantation Program, Clinical Research Division - Fred Hutch Cancer Center 
•Steven Devine, MD (moderator) 
Chief Medical Officer - NMDP/Be The Match
Associate Scientific Director - CIBMTR-NMDP/Be The Match 

This activity is jointly provided by The France Foundation and the National Marrow Donor Program (NMDP)/Be The Match. 

In support of improving patient care, this activity has been planned and implemented by The France Foundation and the NMDP/Be The Match. The France Foundation is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 


Physicians: The France Foundation designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Nurses: The France Foundation designates this activity for 1.0 contact hours. 

All other healthcare professionals completing this course will be issued a statement of participation.  
For additional CME/CE information and disclosures, click here

CE Accreditation Period: N/A
Topic(s): Aplastic Anemia

Watch experts Régis Peffault de Latour, Alicia Rovó, and Phillip Scheinberg as they discuss aplastic anemia diagnosis and treatment options supported by patient cases. Watch the full webcast on Demand or select an individual presentation.

CE Accreditation Period: 01/16/2023 to 01/16/2025
Topic(s): Related Bone Marrow Failure Diseases and Malignancies, Myelodysplastic Syndromes (MDS), Acute Myeloid Leukemia (AML)

A Thread To Pull: Unraveling the Complexities of Myeloid Malignancies

This complimentary CME satellite symposium that provides an in-depth and up-to-date review of research related to biology, prognosis, natural history, and therapeutic management of patients with myeloid malignancies including PNH, MDS, AML, MPN and related myeloid malignancies. The overall goal of the program is to bring together leaders in disease research and clinical practice to explore solutions to improving the care of these patient populations.

CE Accreditation Period: 06/03/2022 to 06/03/2023
Topic(s): Myelodysplastic Syndromes (MDS)

Program Description: Join Dr. Naval Daver and Dr. Guillermo Garcia-Manero from MD Anderson Cancer Center to discuss current treatment options and unmet needs for different patient populations with MDS. The expert panel will further explore emerging targeted and combination therapies, including rationale for use, novel mechanisms of action, and the latest clinical data. As an issue of great importance, the evidence on disparities in clinical trials will be reviewed and strategies shared to educate patients on the clinical-trial process and its benefits, while encouraging enrollment when appropriate. Patient interviews will ensure the education remains patient-focused by providing their experiences with treatment and the clinical decision-making process. 

Register and view here:

CE Accreditation Period: 05/26/2022 to 05/26/2023
Topic(s): Paroxysmal Nocturnal Hemoglobinuria (PNH)

Complement Regulation and Unmet Needs in the Treatment of Paroxysmal Nocturnal Hemoglobinuria 
Watch now on-demand
Featured Speakers 

Dr. Satheeth Chonat, M.D 
Assistant Professor, Pediatric Hematology 
Emory University School of Medicine 
Children’s Healthcare of Atlanta

Dr. Carlos de Castro  
Professor of Medicine 
Department of Medicine, Division of Hematologic Malignancies & Cell Therapy 
Duke University 
Theresa Elgin 
Patient Participant 

Learning Objectives:

  • Describe strategies to decrease delays in the diagnosis of PNH
  • Review existing and emerging therapeutics agents for PNH that target the complement cascade
  • Discuss management of persistent challenges experienced by patients with PNH that impact quality of life
  • Identify special circumstances that require counseling of patients with PNH
Share with